Journal list Promote Sponsor
verified SJR 1,138 · Q1 • database Scopus / SJR & Web of Science indexed
Journal of Cell Communication and Signaling
Netherlands · John Wiley and Sons Inc
workspace_premium Q1 — Cell Biology lock_open Open Access

Journal of Cell Communication and Signaling

Journal of Cell Communication and Signaling is a journal indexed in SJR in Cell Biology and Molecular Biology with an H index of 62. It has a price of 2590 €. It has an SJR impact factor of 1,138 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,138.

ISSN: 1873-9601
Publisher: John Wiley and Sons Inc
Category: Cell Biology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,138 Q1
H-index 62
Acceptance rate pie_chart
31%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
2.590 € Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,138

H-index

62

Docs (year)

30

Docs 3y

205

Total refs

1795

Cites 3y

758

Citable 3y

190

Cites/Doc 2y

3.99

Ref/Doc

59.83

Immediate OA

2590 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Biphasic increase of gap junction coupling induced by dipyridamole in the rat aortic A-10 vascular smooth muscle cell line

View more

Wnt 10b activates the CCN2 promoter in NIH 3T3 fibroblasts through the Smad response element

View more

Communication is the key.

View more

Come together, right now....

View more

CCN6 (WISP3): a new anti-cancer therapy?

View more

CCN3-mediated promotion of sulfated proteoglycan synthesis in rat chondrocytes from developing joint heads

View more

CCN2/decorin interactions: a novel approach to combating fibrosis?

View more

CCN2: a bona fide target for anti-fibrotic drug intervention

View more

CCN2 is not required for skin development

View more

CCN1 contributes to skin connective tissue aging by inducing age-associated secretory phenotype in human skin dermal fibroblasts

View more

CCN proteins are part of a multilayer complex system: a working model

View more

Calcium and copper transport ATPases: analogies and diversities in transduction and signaling mechanisms

View more
SHOW MORE ARTICLES

Breast cancer at bone metastatic sites: recent discoveries and treatment targets

View more

A functional analysis of Wnt inducible signalling pathway protein -1 (WISP-1/CCN4)

View more

B cell block: is rituximab a new possible treatment for systemic sclerosis?

View more

Association of the metastatic phenotype with CCN family members among breast and oral cancer cells

View more

Assessment of circulating Wnt1 inducible signalling pathway protein 1 (WISP-1)/CCN4 as a novel biomarker of obesity

View more

Aspirin suppresses tumor cell-induced angiogenesis and their incongruity

View more

Analysis of CCN2 promoter activity in PANC-1 cells: regulation by ras/MEK/ERK

View more

An integrated map of corticotropin-releasing hormone signaling pathway

View more

Aberrant Wnt Signaling Pathway in the Hematopoietic Stem/Progenitor Compartment in Experimental Leukemic Animal

View more

A sticky situation: CCN1 promotes both proliferation and apoptosis of cancer cells

View more

A reproducible scaffold-free 3D organoid model to study neoplastic progression in breast cancer

View more

A proposal of an in vitro model which mimics in situ areas of carcinoma

View more

FAQs